Synendos Therapeutics

Switzerland - Basel

Biotechnology

Website LinkedIn

Focus: Small molecule for cns disorder

Synendos Therapeutics is a life sciences company focused on Small molecule for cns disorder.

Neurology

Funding Stage

PUBLIC

Employees

201-500

Open Jobs

Pipeline & Clinical Trials

SYT-510

Healthy

Phase 1

Clinical Trials (2)

NCT07478744A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder

Phase 2

NCT06670950A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants

Phase 1

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Founded: 2007

Portfolio: 2 clinical trials